Search

Your search keyword '"Ficarra, G."' showing total 465 results
Start Over Author "Ficarra, G."
465 results on '"Ficarra, G."'

51. Trans-CHER-Lob: A Biomarker Analysis of the Randomized Phase II Study of Neoadjuvant Chemotherapy Plus Trastuzumab, Lapatinib or Combined Trastuzumab and Lapatinib in HER2 Positive Operable Breast Cancer

Author

Guarneri, V, Frassoldati, A, Ficarra, G, Maiorana, A, Bettelli, S, Bottini, A, Cagossi, K, Bisagni, G, Ravaioli, A, Amadori, D, Musolino, A, Cavanna, L, Orlando, L, Giardina, G, Piacentini, F, Bagnalasta, M, and Conte, Pierfranco

Subjects
pAKT, Ki67, dual HER2 blockade, lapatinib, trastuzumab
Published
2011

52. Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: a retrospective multicenter study

Author

Dieci, M.V., primary, Criscitiello, C., additional, Goubar, A., additional, Viale, G., additional, Conte, P., additional, Guarneri, V., additional, Ficarra, G., additional, Mathieu, M.C., additional, Delaloge, S., additional, Curigliano, G., additional, and Andre, F., additional

Published
2015
Full Text
View/download PDF

65. Operable Breast Cancer: preliminary results of a phase II, double blind, placebo controlled, randomized trial of preoperative chemotherapy +/- gefitinib with biomarkers evaluation

Author

Guarneri, V., Frassoldati, A., Ficarra, G., Giovannelli, S., Borghi, F., Puglisi, F., Mansutti, M., Andreetta, C., Banna, G., Masci, G., Santoro, A., Boni, C., Giancarlo Bisagni, Michelotti, A., Crispino, S., and Conte, Pf

Subjects
breast cancer, EGFR, Chemotherapy, Gefitinib, neoadjuvant therapy, MAPK
Published
2005

73. Male breast myofibroblastoma. Case report

Author

Palladino, L., Mosca, D., Ganz, E., Ficarra, G., Buttazzi, A., and Speranza, M.

Subjects
male, muscle tissue, Myofibroblastoma, Neoplasms, Breast neoplasms, male, Neoplasms, muscle tissue, Breast neoplasms
Published
1998

78. Primary solitary meningioma of the lung

Author

Maiorana, Antonino, Ficarra, G., Fano, Rita Adriana, and Spagna, G.

Subjects
Male, Microscopy, Electron, Lung Neoplasms, meningioma, lung, Humans, Solitary Pulmonary Nodule, Meningioma, Aged
Abstract

Light microscopic, ultrastructural and immunohistochemical features of a case of primary meningioma of the lung are described in this report. The lesion was incidentally discovered in the right lung of a 68-year-old man and treated by lobe resection. No evidence of recurrence or metastasis has been detected 2 years after surgery. The literature is reviewed and the differential diagnosis from other neoplasms presenting as coin lesions in the lung is stressed. Different histogenetical theories and the relation to so-called "minute pulmonary chemodectomas" are discussed.

Published
1996

82. PD05-01: Trans-CHER-Lob: A Biomarker Analysis of the Randomized Phase II Study of Neoadjuvant Chemotherapy Plus Trastuzumab, Lapatinib or Combined Trastuzumab and Lapatinib in HER2 Positive Operable Breast Cancer.

Author

Guarneri, V, primary, Frassoldati, A, additional, Ficarra, G, additional, Maiorana, A, additional, Bettelli, S, additional, Bottini, A, additional, Cagossi, K, additional, Bisagni, G, additional, Ravaioli, A, additional, Amadori, D, additional, Musolino, A, additional, Cavanna, L, additional, Orlando, L, additional, Giardina, G, additional, Piacentini, F, additional, Bagnalasta, M, additional, and Conte, P, additional

Published
2011
Full Text
View/download PDF

96. Update on oral lichen planus: etiopathogenesis and management

Author

Scully, C, Beyli, M, Ferreiro, M C, Ficarra, G, Gill, Y, Griffiths, M, Holmstrup, P, Mutlu, S, Porter, S, Wray, D, Scully, C, Beyli, M, Ferreiro, M C, Ficarra, G, Gill, Y, Griffiths, M, Holmstrup, P, Mutlu, S, Porter, S, and Wray, D

Abstract

Lichen planus (LP) is a relatively common disorder of the stratified squamous epithelia, which is, in many ways, an enigma. This paper is the consensus outcome of a workshop held in Switzerland in 1995, involving a selection of clinicians and scientists with an interest in the condition and its management. The oral (OLP) eruptions usually have a distinct clinical morphology and characteristic distribution, but OLP may also present a confusing array of patterns and forms, and other disorders may clinically simulate OLP. Lesions may affect other mucosae and/or skin. Lichen planus is probably of multifactorial origin, sometimes induced by drugs or dental materials, often idiopathic, and with an immunopathogenesis involving T-cells in particular. The etiopathogenesis appears to be complex, with interactions between and among genetic, environmental, and lifestyle factors, but much has now been clarified about the mechanisms involved, and interesting new associations, such as with liver disease, have emerged. The management of lichen planus is still not totally satisfactory, and there is as yet no definitive treatment, but there have been advances in the control of the condition. There is no curative treatment available; immunomodulation, however, can control the condition. Based on the observed increased risk of malignant development, OLP patients should be offered regular follow-up examination from two to four times annually and asked to report any changes in their lesions and/or symptoms. Follow-up may be particularly important in patients with atrophic/ulcerative/erosive affections of the tongue, the gingiva, or the buccal mucosa. Much more research is required into the genetic and environmental aspects of lichen planus, into the premalignant potential, and into the possible associations with chronic liver, and other disorders. More clinical studies are required into the possible efficacy of immunomodulatory drugs such as pentoxifylline and thalidomide.

Published
1998

Catalog

Books, media, physical & digital resources
See catalog results